How to Buy Biocryst Pharmaceuticals Stock
Biocryst Pharmaceuticals Inc
BioCryst Pharmaceuticals, Inc. , a biotechnology company, discovers novel, oral, and small-molecule medicines.
Biocryst Pharmaceuticals stock last closed at $8.44, up 1.44% from the previous day, and has increased 97.66% in one year. It has overperformed other stocks in the Biotechnology industry by 1.75 percentage points. Biocryst Pharmaceuticals stock is currently +103.37% from its 52-week low of $4.15, and -11.16% from its 52-week high of $9.50.
There are currently 208.96M BCRX shares outstanding. The market value of BCRX is $1.76B. In the last 24 hours, 4.97M BCRX shares were traded.
How to Buy Biocryst Pharmaceuticals Stock
Not sure how to invest in Biocryst Pharmaceuticals stock? Here's how.
- Choose where to buy Biocryst Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you determine where to buy Biocryst Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Choose your payment method and add your details.
- Evaluate Biocryst Pharmaceuticals stock: The Biocryst Pharmaceuticals ticker symbol is BCRX. Is Biocryst Pharmaceuticals stock a good investment? Should you buy shares of BCRX? How do BCRX's underlying business fundamentals look? Do top analysts think Biocryst Pharmaceuticals is a good buy? Why has BCRX's stock price moved recently? (Hint: Our stock research website can help you understand if BCRX is a good stock to buy).
- Execute your BCRX purchase: Decide if you will purchase BCRX shares at the current market price or use a limit order to purchase BCRX stock at a specific price.
- Get updates on your BCRX investment: Create a watchlist to key updates about your investment in Biocryst Pharmaceuticals stock.
Step 1: Choose where to buy Biocryst Pharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy BCRX shares.
Our favorite brokerage: eToro
We believe that eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Technology to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the right brokerage, it's time to fill out some personal details so you can buy BCRX today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to create your new trading account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have created your account on the best stock app, you need to deposit funds:
Check out this video walkthrough to see the process of depositing money into your investment account.
Step 4: Evaluate Biocryst Pharmaceuticals stock
After you have selected the best place to buy Biocryst Pharmaceuticals stock, it's important to evaluate their stock prior to buying, so you truly wrap your head around the risk as well as the opportunity.
Overview of key BCRX info
Biocryst Pharmaceuticals Due Diligence Checks
WallStreetZen was built to help average investors perform more in-depth fundamental analysis.
You can see all of the due diligence checks on BCRX's stock page.
Is BCRX stock undervalued?
Analysts use many financial metrics, analyses, models, and charts to gauge BCRX's fair value.
You can do more valuation analysis on BCRX's stock here.
A quick look at BCRX Financials
Pros:
- BCRX profit margin has gone up from -68.4% to -19.7% in the past year.
- BCRX has $321.06M in cash and short term investments. This is enough to cover its annual cash burn of $53.14M.
- There are more short-term assets than short-term liabilities on the BCRX balance sheet.
- BCRX has cash burn of 53144000. It has sufficient cash and short-term investments to cover this for at least one year.
Cons:
- There are more long-term liabilities than short-term assets on the BCRX balance sheet.
- Total BCRX debt is still negative.
- BCRX debt to equity ratio of -2.03 is negative.
Do analysts think it's a good time to buy Biocryst Pharmaceuticals stock
Out of 7 Wall Street analysts who monitor BCRX, the consensus analyst rating on Biocryst Pharmaceuticals is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Latest BCRX Analyst Ratings
Liisa Bayko, a top 8% analyst from Evercore ISI Group maintains BCRX with a buy rating and raises their BCRX price target from $10.00 to $12.00, on Jan 13, 2025.
Gena Wang, a bottom 5% analyst from Barclays maintains BCRX with a hold rating and raises their BCRX price target from $7.00 to $8.00, on Nov 5, 2024.
You can dive deeper into what analysts are projecting on the Biocryst Pharmaceuticals stock forecast page.
BCRX Trading Indicators
How is BCRX performing as a company?
Last year, BCRX revenue was $450.71M. Over the last five year, BCRX's revenue has increased by 55.97% per year. This was faster than the Biotechnology industry average of 45.47%.
Learn more about BCRX's earnings and revenue performance here.
Latest Insiders Trades at BCRX
Over the last 12 months, insiders at BCRX have bought more shares than they have sold.
Helen M. Thackray, Chief RD Officer of BCRX, was the latest BCRX insider to sell. They sold $56,437.50 worth of BCRX shares on Mar 31, 2025.
Research more about who owns BCRX shares here.
Does BCRX provide a stable income stream?
No, Biocryst Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about BCRX
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your BCRX purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are generally the best for newer investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a particular price, use a limit order.
Click the Open button and your broker will execute your order.
If you require additional help buying stocks on eToro, watch the helpful video below:
Step 6: Get updates on your BCRX investment
Now that you own some shares in BCRX, you'll want to stay up-to-date on your company.
Add BCRX to a watchlist to monitor your BCRX stock.
BCRX Feed
How to Buy Stock in Biocryst Pharmaceuticals
To reiterate, here are the 6 steps to buy Biocryst Pharmaceuticals stock:
- Choose where to buy Biocryst Pharmaceuticals stock
- Sign up for a brokerage account
- Deposit money your brokerage account
- Evaluate Biocryst Pharmaceuticals stock
- Execute your BCRX purchase
- Get updates on your BCRX investment
If you are looking for a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to watch your investment in Biocryst Pharmaceuticals, create your watchlist below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.